by Mark Chiang

由马克·蒋

Share To

分享到

Sanofi has announced plans to invest up to $25 million in Adagene, a biotechnology company focused on antibody-based therapeutics. The investment aims to support Adagene’s research and development initiatives, including the clinical advancement of its investigational drug muzastotug.

赛诺菲宣布计划向专注于抗体治疗的生物技术公司Adagene投资高达2500万美元。这项投资旨在支持Adagene的研发计划，包括推进其研究性药物muzastotug的临床进展。

The funding will provide Adagene with resources to continue its work in developing innovative treatments. Muzastotug, one of the company’s key projects, is currently undergoing clinical development as part of its pipeline. The collaboration reflects Sanofi’s ongoing interest in supporting advancements in biopharmaceutical innovation..

这笔资金将为天演药业提供资源，以继续其在开发创新治疗方案方面的工作。该公司的一个关键项目——Muzastotug，目前正在作为其研发管线的一部分进行临床开发。此次合作反映了赛诺菲对支持生物制药创新发展的持续兴趣。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: July 2, 2025

日期：2025年7月2日

Related posts:

相关内容：

Biosimilar Market Growth: Over 100 Biosimilars Approved Globally Drive Pharmaceutical Industry Shift.

生物仿制药市场增长：全球范围内获批的100多种生物仿制药推动制药行业转型。

Sasha Watson Highlights ctDNA’s Potential for Early Colon Cancer Detection and Personalized Treatment Strategies

萨沙·沃森强调了ctDNA在早期结肠癌检测和个性化治疗策略中的潜力。

Pharmaceutical Companies Shift to Hybrid Strategies as Virtual Meetings and Digital Tools Gain Traction

随着虚拟会议和数字工具的兴起，制药公司转向混合策略

Study Explores Link Between Omega-3 Fatty Acids and Depression Relief Through Anti-Inflammatory Effects

研究探讨了欧米伽-3脂肪酸通过抗炎作用缓解抑郁的关联

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作：

[email protected]

[email protected]

Author

作者

Mark Chiang

马克·蒋

Related Post

相关内容

News Flash

新闻快讯

Senate Passes Tax-Cut Bill Reducing Medicaid Funding and Repealing ACA Individual Mandate

参议院通过减税法案，削减医疗补助资金并废除《平价医疗法案》个人强制条款

2025-07-10

2025年7月10日